# Cumberland Pharmaceuticals clinical trials: 49 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 49 trials with Cumberland Pharmaceuticals as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Cumberland Pharmaceuticals: 49 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/cumberland-pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 49
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 49, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 7, 2022 | NCT05571059 | Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Cumberland Pharmaceuticals | Phase 2 | Recruiting | Idiopathic Pulmonary Fibrosis | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05571059) |
| August 2, 2018 | NCT03611010 | Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients | Cumberland Pharmaceuticals | Phase 2 | Completed | Hypercholesterolemia, Dyslipidemias | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03611010) |
| November 13, 2017 | NCT03340675 | Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Cumberland Pharmaceuticals | Phase 2 | Completed | Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03340675) |
| January 23, 2017 | NCT03028350 | Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) | Cumberland Pharmaceuticals | Phase 2 | Completed | Asthma, Aspirin-Induced | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03028350) |
| June 16, 2016 | NCT02802228 | Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients | Cumberland Pharmaceuticals | Phase 2 | Completed | Portal Hypertension, Liver Cirrhosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02802228) |
| February 15, 2016 | NCT02682511 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | Cumberland Pharmaceuticals | Phase 2 | Active not recruiting | Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic, Skin Diseases... | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02682511) |
| October 22, 2015 | NCT02583399 | Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients | Cumberland Pharmaceuticals | Phase 4 | Completed | Pain, Fever | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02583399) |
| November 11, 2014 | NCT02288234 | Telavancin Observational Use Registry (TOUR) | Cumberland Pharmaceuticals | Observational | Completed | Hospital Acquired Bacterial Pneumonia, Complicated Skin and Skin Structure Infections, Ventilator Associated Bacterial... | 1,063 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02288234) |
| August 13, 2014 | NCT02216357 | Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease | Cumberland Pharmaceuticals | Phase 2 | Completed | Aspirin Exacerbated Respiratory Disease (AERD) | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02216357) |
| August 4, 2014 | NCT02208063 | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | Cumberland Pharmaceuticals | Phase 3 | Terminated | Bacteremia | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02208063) |
| April 25, 2014 | NCT02123017 | Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy | Cumberland Pharmaceuticals | Phase 2 | Completed | Colonoscopy Preparation | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02123017) |
| December 17, 2013 | NCT02013141 | Telavancin Pediatric PK Study (Ages \>12 Months to 17 Years) | Cumberland Pharmaceuticals | Phase 1 | Terminated | Gram-Positive Bacterial Infections | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02013141) |
| July 17, 2013 | NCT01901393 | Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery | Cumberland Pharmaceuticals | Phase 4 | Completed | Pain | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01901393) |
| June 26, 2013 | NCT01887470 | 2 Regimens of Lactulose for Colonoscopy Preparation in Adults | Cumberland Pharmaceuticals | Phase 2 | Completed | Colonoscopy Preparation | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01887470) |
| July 26, 2012 | NCT01650519 | A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery | Cumberland Pharmaceuticals | Phase 4 | Completed | Arthroscopic Knee Surgery | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01650519) |
| October 13, 2011 | NCT01451411 | A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or... | Cumberland Pharmaceuticals | Phase 3 | Terminated | Hyponatremia | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01451411) |
| September 19, 2011 | NCT01436500 | Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients | Cumberland Pharmaceuticals | Phase 2 | Completed | Hepatorenal Syndrome | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01436500) |
| June 9, 2011 | NCT01370148 | A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan | Cumberland Pharmaceuticals | Phase 1 | Completed | Liver Disease | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01370148) |
| April 13, 2011 | NCT01334957 | Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Cumberland Pharmaceuticals | Phase 4 | Completed | Pain | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01334957) |
| April 13, 2011 | NCT01334944 | Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Cumberland Pharmaceuticals | Phase 4 | Completed | Pain, Fever | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01334944) |
| April 11, 2011 | NCT01332253 | Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy | Cumberland Pharmaceuticals | Phase 3 | Completed | Tonsillectomy | 161 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01332253) |
| November 11, 2010 | NCT01238796 | A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin | Cumberland Pharmaceuticals | Phase 1 | Completed | Kidney Diseases, End Stage Renal Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01238796) |
| May 26, 2010 | NCT01131000 | Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients | Cumberland Pharmaceuticals | Phase 3 | Completed | Fever | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01131000) |
| May 26, 2010 | NCT01130324 | VIBATIV Pregnancy Registry | Cumberland Pharmaceuticals | Observational | Withdrawn | Pregnancy | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01130324) |
| May 7, 2010 | NCT01118663 | Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | Cumberland Pharmaceuticals | Phase 3 | Terminated | Acetaminophen Overdose | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01118663) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 2 | 15 |
| Phase 3 | 19 |
| Phase 4 | 7 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 41 |
| Terminated | 5 |
| Active not recruiting | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hyponatremia | 9 |
| Pain | 6 |
| Fever | 5 |
| Gram-Positive Bacterial Infections | 4 |
| Edema | 3 |
| Burns | 3 |
| Staphylococcal Infections | 3 |
| Kidney Diseases | 2 |
| Liver Cirrhosis | 2 |
| Hypertension, Portal | 2 |
| Liver Diseases | 2 |
| Asthma, Aspirin-Induced | 2 |
| Abscess | 2 |
| Cellulitis | 2 |
| Ulcer | 2 |
| Wound Infection | 2 |
| Staphylococcal Skin Infections | 2 |
| Pneumonia, Bacterial | 2 |
| Kidney Failure, Chronic | 1 |
| Diabetes Insipidus | 1 |
| Constipation | 1 |
| Hepatorenal Syndrome | 1 |
| Scleroderma, Diffuse | 1 |
| Scleroderma, Systemic | 1 |
| Scleroderma, Limited | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Radiology practices in the United States](https://specstream.ai/data/businesses/radiology-practices/united-states)
- [AV equipment rental companies in the United States](https://specstream.ai/data/businesses/av-equipment-rental-companies/united-states)
- [Escrow companies in the United States](https://specstream.ai/data/businesses/escrow-companies/united-states)
- [Nepalese restaurants in the United States](https://specstream.ai/data/businesses/nepalese-restaurants/united-states)
- [Translation companies in the United States](https://specstream.ai/data/businesses/translation-companies/united-states)
